Can-Fite BioPharma (CANF) Net Income towards Common Stockholders (2014 - 2023)
Can-Fite BioPharma (CANF) posted Net Income towards Common Stockholders of -$9.83 million for FY2025, compared with -$7.88 million in FY2024.
Powered by 
Analysis
Can-Fite BioPharma (CANF) Net Income towards Common Stockholders (2014 - 2023) Analysis & Trends
Since FY2013, Can-Fite BioPharma has reported Net Income towards Common Stockholders for 12 years.
- The FY2025 figure stands as the lowest annual Net Income towards Common Stockholders since FY2021.
- Business Quant data shows CANF's Net Income towards Common Stockholders at -$7.88 million in FY2024, -$7.63 million in FY2023, -$7.63 million in FY2022 and -$10.03 million in FY2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Can-Fite BioPharma | 1.79 Mn | -17.91 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -1.65 Mn |
| Sep 30, 2023 | -1.76 Mn |
| Jun 30, 2023 | 2.55 Mn |
| Mar 31, 2023 | -2.55 Mn |
| Dec 31, 2022 | -480,000.00 |
| Sep 30, 2022 | -2.53 Mn |
| Jun 30, 2022 | 2.43 Mn |
| Mar 31, 2022 | -2.43 Mn |
| Dec 31, 2021 | -4.12 Mn |
| Sep 30, 2021 | -3.40 Mn |
| Jun 30, 2021 | -3.22 Mn |
| Mar 31, 2021 | -1.88 Mn |
| Dec 31, 2020 | -3.63 Mn |
| Sep 30, 2020 | -2.58 Mn |
| Jun 30, 2020 | -3.89 Mn |
| Dec 31, 2019 | -1.75 Mn |
| Sep 30, 2019 | -2.95 Mn |
| Jun 30, 2019 | -6.73 Mn |
| Mar 31, 2019 | 1.83 Mn |
| Dec 31, 2018 | -9.71 Mn |
API Access
Can-Fite BioPharma Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=CANF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "CANF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=CANF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();